Stock Scorecard



Stock Summary for Novo Nordisk (NVO) - $52.41 as of 8/18/2025 11:06:25 AM EST

Total Score

17 out of 30

Safety Score

64 out of 100

Currently on the following lists
None
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for NVO

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for NVO

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for NVO

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for NVO

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for NVO (64 out of 100)

Stock Price Rating (Max of 10) 9
Historical Stock Price Rating (Max of 10) 9
Stock Price Trend (Max of 10) 0
Book Value (Max of 10) 8
Book Value to Price (Max of 10) 1
Analyst Buy Ratings (Max of 5) 3
Analyst Strong Buy Ratings (Max of 5) 3
Dividend Yield Percentage (Max of 10) 6
Operating Margin (Max of 10) 6
Trading Volume (Max of 10) 10
Price to Earnings (Max of 10) 9
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for NVO

Novo Nordisk Scores Wegovy Win, Eyes Rebound Near 52-Week Lows - Novo Nordisk ( NYSE:NVO ) 8/18/2025 3:53:00 PM
Why Is GoodRx Stock Skyrocketing Monday? - GoodRx Holdings ( NASDAQ:GDRX ) 8/18/2025 3:36:00 PM
Why Novo Nordisk Stock Popped Monday 8/18/2025 2:32:00 PM
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio 8/18/2025 1:40:00 PM
Lilly Stock Down 5% This Month: Should You Buy the Dip? 8/18/2025 1:13:00 PM
Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients 8/18/2025 1:00:00 PM
What's Going On With Novo Nordisk Stock Monday? - Novo Nordisk ( NYSE:NVO ) 8/18/2025 10:16:00 AM
Novo Nordisk shares pop 5% after Wegovy receives U.S. approval for liver disease 8/18/2025 9:00:00 AM
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Novo Nordisk A/S of Class Action Lawsuit and Upcoming Deadlines - NVO - Novo Nordisk ( NYSE:NVO ) 8/17/2025 2:47:00 PM
1 Stock Down 40% This Year to Buy and Hold 8/17/2025 2:00:00 PM

Financial Details for NVO

Company Overview

Ticker NVO
Company Name Novo Nordisk
Country USA
Description Novo Nordisk A / S, a healthcare company, is dedicated to the research, development, manufacture and marketing of pharmaceutical products globally. The company is headquartered in Bagsvaerd, Denmark.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 6/30/2025
Next Earnings Date 11/5/2025

Stock Price History

Last Day Price 52.41
Price 4 Years Ago 53.04
Last Day Price Updated 8/18/2025 11:06:25 AM EST
Last Day Volume 17,622,514
Average Daily Volume 20,262,503
52-Week High 137.52
52-Week Low 45.05
Last Price to 52 Week Low 16.34%

Valuation Measures

Trailing PE 13.00
Industry PE 43.35
Sector PE 59.06
5-Year Average PE 23.66
Free Cash Flow Ratio 9.58
Industry Free Cash Flow Ratio 15.81
Sector Free Cash Flow Ratio 30.26
Current Ratio Most Recent Quarter 0.78
Total Cash Per Share 5.47
Book Value Per Share Most Recent Quarter 37.82
Price to Book Ratio 8.61
Industry Price to Book Ratio 31.11
Sector Price to Book Ratio 26.93
Price to Sales Ratio Twelve Trailing Months 0.73
Industry Price to Sales Ratio Twelve Trailing Months 34.46
Sector Price to Sales Ratio Twelve Trailing Months 15.21
Analyst Buy Ratings 3
Analyst Strong Buy Ratings 1

Share Statistics

Total Shares Outstanding 3,368,560,000
Market Capitalization 176,546,229,600
Institutional Ownership 9.72%

Dividends

Ex-Dividend Date 3/31/2025
Previous Dividend Amount 0.5169
Current Dividend Amount 1.0992
Total Years Dividend Increasing 5
Trailing Annual Dividend Rate 1.62
Trailing Annual Dividend Yield 3.17%
Forward Annual Dividend Rate 2.20
Forward Annual Dividend Yield 4.31%
5-Year Dividend Payments Count 9
3-Year Average Dividend Yield 1.71%
5-Year Average Dividend Yield 1.34%
1-Year Dividend Growth Rate Percentage 51.96%
3-Year Dividend Growth Rate Percentage 23.27%
5-Year Dividend Growth Rate Percentage 31.46%
All-Time Dividend Growth Rate Percentage 9.39%
Dividend Payout Ratio 41.23%

Income Statement

Quarterly Earnings Growth YOY 32.70%
Annual Earnings Growth 20.68%
Reported EPS 12 Trailing Months 3.92
Reported EPS Past Year 12.49
Reported EPS Prior Year 13.95
Net Income Twelve Trailing Months 111,068,000,000
Net Income Past Year 100,988,000,000
Net Income Prior Year 83,683,000,000
Quarterly Revenue Growth YOY 12.90%
5-Year Revenue Growth 18.94%
Operating Margin Twelve Trailing Months 43.50%

Balance Sheet

Total Cash Most Recent Quarter 18,435,000,000
Total Cash Past Year 15,655,000,000
Total Cash Prior Year 14,392,000,000
Net Cash Position Most Recent Quarter -68,870,000,000
Net Cash Position Past Year -68,591,000,000
Long Term Debt Past Year 84,246,000,000
Long Term Debt Prior Year 15,976,000,000
Total Debt Most Recent Quarter 87,305,000,000
Equity to Debt Ratio Past Year 0.63
Equity to Debt Ratio Most Recent Quarter 0.66
Total Stockholder Equity Past Year 143,486,000,000
Total Stockholder Equity Prior Year 106,561,000,000
Total Stockholder Equity Most Recent Quarter 168,066,000,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 61,989,000,000
Free Cash Flow Per Share Twelve Trailing Months 18.40
Free Cash Flow Past Year 69,659,000,000
Free Cash Flow Prior Year 70,012,000,000

Options

Put/Call Ratio 0.23
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -4.99
MACD Signal -5.00
20-Day Bollinger Lower Band 49.33
20-Day Bollinger Middle Band 65.34
20-Day Bollinger Upper Band 81.34
Beta 0.27
RSI 34.73
50-Day SMA 86.45
150-Day SMA 91.23
200-Day SMA 81.22

System

Modified 8/16/2025 6:19:17 AM EST